A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer

NCT01021059 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Melanoma
Carcinoma, Renal Cell

Interventions

BIOLOGICAL: rh IL-15

Sponsor

National Cancer Institute (NCI)